Genomic Health, Inc. (GHDX): Hedge Funds Cashed Out Too Early
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Genomic Health Inc (GHDX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 0 | $0 | 0% | |
| 2. | Havens Advisors Nancy Havens-Hasty | 0 | $0 | 0% | |
| 3. | Quantamental Technologies Ran Pang | 0 | $0 | 0% | |
| 4. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 5. | BlueCrest Capital Mgmt. Michael Platt And William Reeves | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 37,643,330 | Large Shareholder, Other | 100 | 2019-11-08 | Filing | |
| $27.02 | 89,896 | Large Shareholder, Director | 11,348,958 | 2016-08-15 | Filing | |
| $27.02 | 10,104 | Large Shareholder, Director | 1,758,289 | 2016-08-15 | Filing | |
| $35.82 | 4,735 | Large Shareholder, Director | 301,215 | 2013-06-05 | Filing | |
| $35.82 | 189,886 | Large Shareholder, Director | 11,241,654 | 2013-06-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.94 | 13,183 | Officer | 13,736 | 2019-10-17 | Filing | |
| $67.75 | 4,500 | Officer | 16,417 | 2019-10-08 | Filing | |
| $67.74 | 10,000 | Officer, Director | 68,268 | 2019-10-08 | Filing | |
| $69.01 | 22,560 | Officer | 38,970 | 2019-10-07 | Filing | |
| $71.47 | 25,000 | Officer | 58,795 | 2019-09-17 | Filing |
Institutional Investors' Holdings
News See All
Hedge Funds Have Never Been This Bullish On Genomic Health, Inc. (GHDX)
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would...
Here's What Hedge Funds Think About Genomic Health, Inc. (GHDX)
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Hedge Fund and Insider Trading News: Steve Cohen, Tom Steyer, Landec Corporation (LNDC), Genomic Health, Inc. (GHDX), and More
At a glance, you could argue that Florida has been a money pit for billionaire Tom Steyer’s political network.
Hedge Fund and Insider Trading News: Carl Icahn, Crispin Odey, ValueAct Capital, La Jolla Pharmaceutical (LJPC), New Mountain Finance Corp. (NMFC), and More
Billionaire activist investor Carl Icahn is building a stake in casino company Caesars Entertainment, sources familiar with the situation said. The size of Icahn’s stake is not immediately known.
Should You Buy Genomic Health, Inc. (GHDX)?
Insider Monkey finished processing more than 700 13F filings made by hedge funds and prominent investors. These filings show these funds' portfolio positions as of September 30th.
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker's Baker Bros. Advisors filed an amended 13D.
You can check out Baker Bros. Advisors' latest holdings and filings here.
Please follow Baker Bros.
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
You can access the original SEC filing by clicking here.
Is Genomic Health, Inc. (GHDX) A Good Stock To Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Hedge Funds Are Hoarding Shares of These 5 Small-Caps
Through extensive research we have determined that the best approach to outperform the broader indices is to follow hedge funds into their top small-cap ideas.